Recent News

By Category: Countermeasures

Experimental Anthrax Vaccine Shows Three-Year Stability

(PharmAthene) PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has achieved an important program milestone in its recombinant protective antigen (rPA) anthrax vaccine program and demonstrated 36 month stability of its rPA drug product candidate previously produced at Avecia Biologics Laboratories in the United Kingdom. The stability data were prepared utilizing a variety of Read More »

July 14, 2011
| Filed under Biotechnology and Countermeasures
Share

MicroKit Simplifies Infectious Disease Detection

(Wall Street Journal) Infectious diseases, such as the H1N1 influenza strain, have wrought havoc not only on human populations in recent years but increasingly on critical bits of economic infrastructure such as transport systems and hospitals. Efforts to contain the spread of the viruses are often hampered by the time and complicated processes involved in Read More »

July 13, 2011
| Filed under Asia/Pacific, North America, Biotechnology, and Countermeasures
Share

UK – Terrorism biggest Olympic threat, say police

(Get Surrey) SAFETY and security will be top priorities when next year’s Olympic Games come to the county say Surrey Police. “Last year, we had foot and mouth and something like that could happen at any time. Superintendent Jerry Westerman, the Surrey Police tactical lead for next year’s Games, has outlined the force’s plan to Read More »

July 6, 2011
| Filed under Europe, Bioterrorism, and Countermeasures
Share

Universal Detection Technology Wins Tender for Biological Weapon Detection Equipment From the Singapore Civil Defense Force

(Press Release) LOS ANGELES, CA-Universal Detection Technology, a developer of early-warning monitoring technologies that protect against biological, chemical, and radiological threats, announced today that is has won a tender for Biological Weapon Detection Equipment from the Singapore Civil Defense Force. The tender included equipment for the detection of Anthrax, Ricin, Botulinum, Y. Pestis (Plague) and Read More »

June 29, 2011
| Filed under Asia/Pacific, North America, Biological Weapons, Biotechnology, and Countermeasures
Share

HHS Curbs Smallpox Antiviral Purchase

(GSN Daily News) The U.S. Health and Human Services Department has dropped an option in a $433 million smallpox antiviral drug contract to purchase 12 million additional courses of the treatment, the Corvallis, Ore., Gazette Times reported (see GSN, May 17, 2011). The department’s Biomedical Advanced Research and Developmental Authority included the option in the Read More »